Abstract
The authors revise the concept of ALK-negative anaplastic large cell lymphoma (ALCL) in the light of the recently updated WHO classification of Tumors of Hematopoietic and Lymphoid Tissues both on biological and clinical grounds. The main histological findings are illustrated as well as the phenotypic, molecular and clinical characteristics. Finally, the biological rationale for possible innovative targeted therapies is presented. © S.A. Pileri et al., 2011.
Author supplied keywords
Cite
CITATION STYLE
Pileri, S. A., Agostinelli, C., Bacci, F., Sabattini, E., Sagramoso, C., Falini, B., & Piccaluga, P. P. (2011). Pathobiology of ALK-negative anaplastic large cell lymphoma. Pediatric Reports, 3(2S), 8–10. https://doi.org/10.4081/pr.2011.s2.e5
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
